ArticleGenome medicine2017

A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis.

Colin J Ross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.